AGER and hepatocellular carcinoma: To test this hypothesis, we designed a multicenter case-control study and genotyped seven widely-studied polymorphisms from HMGB1 and RAGE genes among 540 hepatocellular carcinoma patients and 540 age- and gender-matched controls.